CRC mortality decreasing more slowly in Hispanics

Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Mortality rates from colorectal cancer (CRC) are declining at a much slower rate in Hispanic patients than in non-Hispanic whites (NHW).

Why this matters

  • Studies suggest Hispanic patients have lower rates of screening and higher rates of late-stage diagnosis.

Study design

  • CRC deaths from the Surveillance, Epidemiology, and End Results database.
  • Funding: National Cancer Institute.

Key results

  • Of 48,316 deaths from CRC overall, 5547 were in Hispanic patients.
  • Between 2000 and 2011, CRC mortality decreased 15.1% in NHW but only 5.9% in Hispanic patients.
  • The mortality rate from localized disease increased 3.3% in Hispanics in 2000-2011 but decreased 10.9% in NHW.
  • Mortality from regional disease decreased 20.1% in NHW but dropped only 6.6% in Hispanics.  

Limitations

  • No data on treatment information.